Randomised trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin

The Lancet

Volumn 344, Issue 8922, 1994, Pages 581-582

  Barrioz, T ^a   Besson, I ^a   de Ledinghen, V ^a   Silvain, C ^a   Beauchant, M ^a   Ingrand, P ^b  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE POITIERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NORFLOXACIN; URSODEOXYCHOLIC ACID;

ARTICLE; BILE DUCT OBSTRUCTION; BILIARY TRACT CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; FRANCE; HOSPITALIZATION; HUMAN; OBSTRUCTIVE JAUNDICE; OCCLUSION; PANCREAS CANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STENT; SURVIVAL;

EID: 0028124108     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)91967-4     Document Type: Article

References (9)

1. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction
2. Clogging of biliary endoprostheses: a new perspective
3. Physicochemical and bacteriological analysis of the contents of occluded biliary endoprostheses
4. Bacterial invasion of the biliary system by way of the portal-venous system
5. Pharmacologic treatment of cholestasis
6. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage
7. A placebo controlled study on the efficacy of aspirin and doxycycline in preventing clogging of biliary endoprostheses
8. Prophylaxis of biliary stent blockage using cyclical antibiotics and ursodeoxycholic acid
9. Ciprofloxacin prevents stent blockage in an animal model